Rituxan Hycela and Bone marrow suppression
Result of checking the interaction of drug Rituxan Hycela and disease Bone marrow suppression for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Myelosuppression has been reported during administration of rituximab. Leukopenia and thrombocytopenia occur more frequently than anemia. Severe myelosuppression has been reported rarely. Therapy with rituximab should be administered cautiously in patients with severe bone marrow suppression. Clinical monitoring of hematopoietic function is recommended.
- "Product Information. Rituxan (rituximab)." Genentech, South San Francisco, CA.
Generic Name: hyaluronidase / rituximab
Brand Name: Rituxan Hycela
Synonyms: n.a.
Rituxan Hycela - supresja szpiku kostnego 
Rituxan Hycela - supressão da medula óssea 
Rituxan Hycela - penindasan sumsum tulang 
Rituxan Hycela - penekanan sumsum tulang 
Rituxan Hycela - soppressione del midollo osseo 
Rituxan Hycela - suppression de la moelle osseuse 
Rituxan Hycela - Knochenmarksunterdrückung 
Rituxan Hycela - supresión de la médula ósea 
Rituxan Hycela - подавление костного мозга 
Rituxan Hycela - kemik iliği baskılanması 
Rituxan Hycela - تثبيط نقي العظم 
Rituxan Hycela - 骨髓抑制